|
||
Journal of Experimental Medicine, Vol 167, 345-352, Copyright © 1988 by Rockefeller University Press
ARTICLES |
A Lanzavecchia, S Abrignani, D Scheidegger, R Obrist, B Dorken and G Moldenhauer
Basel Institute for Immunology, Switzerland.
We found that three tumor patients treated with mouse mAbs have T cells that recognize processed mouse Ig on autologous APC in a class II- restricted fashion, and we have shown that mouse mAbs directed against various cell surface molecules can be used as antigens to focus these T cells on an MHC class II-positive target of choice.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|